European Archives - Page 394 of 1053 - European Medical Journal

Reframing pharma's bad boy reputation

The pharmaceutical industry is a rich source of material for the small screen, but why is it framed as the perpetual bad boy?

Sanofi’s Dr Juby Jacob-Nara on medical affairs and mentorship

How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.

Diencephalic Syndrome: Anaesthetic Management and Post-Operative Complications

Diencephalic syndrome (DS), first described by Russell in 1951, is a rare cause of failure to thrive in infants and young children with preservation of linear growth.

Innovative Upper Gastrointestinal Stenting

Self-expanding metal stents (SEMS) have been established beyond doubt as an effective tool in the palliative management of malignant gastrointestinal tract strictures.

Increasing Awareness in Beta-Thalassemia

This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.

The Efficacy of Anti-TNFs in Immune-Mediated Disease

TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).

EMJ Gastroenterology 11 [Supplement 5] 2022

TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).

Expert Insights into Updated Advanced HF Management Guidelines Comparing AHA/ACC/HFSA and ESC Guidelines

Discover Professor Antoni Bayés-Genís’ view on the evolution of left ventricular assist devices and his comments related to the AHA/ACC/HFSA guidelines in comparison to the 2021 ESC heart failure guidelines.

Pharma's next move in the online jungle

What lies in wait for pharma in the social media jungle?

Weight Management, Micronutrients, and Supplements in Diabetes

T2D remission (an HbA1c <48 mmol/mol without the use of glucose lowering medications for 6 months), improvements in cardiovascular risk factors, and decreased T2D-associated mortality can be achieved through sustained weight loss.